Mytrex Health Technologies, Inc. (TPEX:4431)
Taiwan · Delayed Price · Currency is TWD 17.60
0.00 (0.00%)
Jul 30, 2026, 1:49 PM CST
TPEX:4431 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 669 | 632 | 917 | 1,136 | 924 | 1,003 | |
Market Cap Growth | -2.14% | -31.08% | -19.29% | 22.93% | -7.83% | -44.43% |
Enterprise Value | 410 | 562 | 790 | 1,145 | 601 | 428 |
Last Close Price | 18.30 | 17.30 | 25.10 | 31.10 | 25.30 | 27.45 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PS Ratio | 0.34 | 0.33 | 0.52 | 0.88 | 0.63 | 3.44 |
PB Ratio | 1.14 | 1.08 | 1.51 | 1.68 | 0.96 | 1.20 |
P/TBV Ratio | 1.33 | 1.26 | 1.78 | 1.93 | 1.44 | 1.21 |
P/FCF Ratio | 3.41 | 3.22 | 40.30 | - | 25.00 | - |
P/OCF Ratio | 3.33 | 3.15 | 28.99 | - | 12.75 | 75.49 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 0.21 | 0.29 | 0.45 | 0.89 | 0.41 | 1.47 |
EV/EBITDA Ratio | 9.00 | 17.40 | - | 246.23 | 16.36 | 18.10 |
EV/FCF Ratio | 2.09 | 2.87 | 34.72 | - | 16.25 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.37 | 0.37 | 0.22 | 0.07 |
Debt / EBITDA Ratio | 3.67 | 3.67 | 18.58 | 12.88 | 3.75 | 1.55 |
Debt / FCF Ratio | 0.83 | 0.83 | 9.86 | - | 5.65 | - |
Net Debt / Equity Ratio | -0.44 | -0.44 | -0.09 | 0.02 | -0.29 | -0.50 |
Net Debt / EBITDA Ratio | -8.00 | -8.00 | 20.71 | 2.13 | -7.56 | -17.62 |
Net Debt / FCF Ratio | -1.32 | -1.32 | -2.33 | -0.38 | -7.51 | 25.31 |
Asset Turnover | 1.67 | 1.67 | 1.46 | 0.94 | 1.21 | 0.26 |
Inventory Turnover | 8.27 | 8.27 | 7.61 | 5.68 | 10.29 | 3.31 |
Quick Ratio | 1.13 | 1.13 | 1.16 | 1.01 | 1.82 | 7.02 |
Current Ratio | 1.58 | 1.58 | 1.71 | 1.52 | 2.40 | 8.01 |
Return on Equity (ROE) | -4.33% | -4.33% | -13.18% | -7.09% | -7.65% | -1.55% |
Return on Assets (ROA) | -1.36% | -1.36% | -4.04% | -3.27% | -2.39% | -0.85% |
Return on Invested Capital (ROIC) | -7.74% | -5.73% | -12.48% | -10.43% | -8.43% | -3.88% |
Return on Capital Employed (ROCE) | -3.80% | -3.80% | -10.50% | -8.80% | -4.10% | -1.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -2.48% | -2.63% | -8.98% | -4.95% | -9.94% | -1.40% |
FCF Yield | 29.34% | 31.04% | 2.48% | -2.29% | 4.00% | -1.64% |
Buyback Yield / Dilution | - | - | - | - | -0.00% | -11.05% |
Total Shareholder Return | - | - | - | - | -0.00% | -11.05% |